Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Morgan Thacker"'
Autor:
Ewan Hunter, Mehrnoush Dezfouli, Christina Koutsothanasi, Adam Wilson, Francisco C. Santos, Matthew Salter, Jurjen W. Westra, Ryan Powell, Ann Dring, Benedict Egan, Matthew Parnall, Morgan Thacker, Jayne Green, Aroul Ramadass, Serene Ng, Chun Ren Lim, Cheah Soon Keat, Ang Tick Suan, Rakesh Raman, Ho Kean Fatt, Fabian Lee Wei Luen, Thomas Guiel, Robert Heaton, Jedd Levine, Alexandre Akoulitchev
Unprecedented advantages in cancer treatment with immune checkpoint inhibitors (ICI) remain limited to a subset of patients. Systemic analyses of the regulatory 3D genome architecture linked to individual epigenetics and immunogenetic controls associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d567116c27bf302f074e5decd9f94b
https://doi.org/10.1101/2021.12.21.21268094
https://doi.org/10.1101/2021.12.21.21268094
Autor:
Alexandre Akoulitchev, Ewan Hunter, Francisco C. Santos, Mehrnoush Dezfouli, Christina Koutsothanasi, Matthew Salter, Ryan Powell, Ann Dring, Benedict Egan, Matthew Parnall, Morgan Thacker, Jayne Green, Aroul Ramadass, Serene Ng, Chun Ren Lim, Thomas Guiel, Robert Heaton, Jedd Levine
Publikováno v:
Journal of Clinical Oncology. 40:e14525-e14525
e14525 Background: Unprecedented advantages in cancer treatments with immune checkpoint inhibitors (ICI) remain limited to a subset of patients, with high demands for development of better biomarkers to access likely clinical response in advance of I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe3763e6025f53d45779fb5cafb9fd6
https://doi.org/10.1200/jco.2022.40.16_suppl.e14525
https://doi.org/10.1200/jco.2022.40.16_suppl.e14525
